Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd   Report issue

Founded: Lianyungang China (1969)

Organization Overview

First Clinical Trial
2007
NCT02734966
First Marketed Drug
2020
fulvestrant (faslodex)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CHIA TAI TIANQING | CHIATAI TIANQING PHARMACEUTICAL Co.,Ltd | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Cttq | CTTQ | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd | JiangSu Chia-Tai Tianqin Pharmacy Co.Ltd | Nanjing Chia-tai Tianqing Pharmaceutical | Zhengda Tianqing Pharmaceutical Group Co., Ltd.